About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
Part 3: Sabrina W. Cole, PharmD
In the third of a three-part series, topics such as drug approvals and shortages, therapeutic interchanges, and pharmacoeconomic assessments are discussed.
C. Lee Ventola, MS
An order form for subcutaneous insulin was created to improve blood glucose control in hospitalized diabetic patients. Although use of the form by the staff was relatively low, teaching health care personnel about hyperglycemia and proper use of the form may help reduce complications after patient discharge.
Sally A. Arif, PharmD, BCPS; and Alisa K. EscaÃ±o, PharmD, BCPS, CDE
Alvimopan (Entereg) for the Management of Postoperative Ileus in Patients Undergoing Bowel Resection
Postoperative ileus is common after surgery, especially abdominal procedures. In clinical studies, alvimopan appeared to speed up gastrointestinal tract recovery, was associated with fewer adverse effects, and led to shorter hospital stays.
Michael Kraft, PharmD, BCNSP; Robert MacLaren, PharmD; Wei Du, PhD; and Gay Owens, PharmD
Sessions covered the ARBITER 6-HALTS trial of ezetimibe (Zetia) and niacin (Niaspan); the HEAAL study of losartan (Cozaar); the relationships between statins, high-density lipoprotein-cholesterol (HDL-C) levels, and cardiovascular events; and the association of higher HDL-C levels with lower rates of breast cancer.
Topics include ecallantide (Kalbitor) for hereditary angioedema; a capsaicin 8% patch (Qutenza) for pain management; and romidepsin (Istodax) for patients with cutaneous T-cell lymphoma.
Marvin M. Goldenberg, PhD, RPh, MS
David B. Nash, MD, MBA, discusses his medication quality subcommittee’s annual assessment of its progress in promoting drug safety.
David B. Nash, MD, MBA
Tips for Increasing Error Reporting
Matthew Grissinger, RPh, FASCP, provides suggestions to improve error-reporting systems.
Matthew Grissinger, RPh, FASCP
FDA Tries to Clarify Rules for Internet Advertising
Stephen Barlas discusses the FDA’s attempt to clarify the rules on Internet advertising of drugs and medical devices.
From Agriflu vaccine to Zyprexa, P&T presents the latest studies and information about FDA approvals, drug indications, product recalls, and industry updates.
Vigabatrin (Sabril), a Gamma-Aminobutyric Acid Transaminase Inhibitor for the Treatment of Two Catastrophic Seizure Disorders
Dr. Martin Cruz reviews vigabatrin (Sabril), a therapy for seizure disorders.
Martin P. Cruz, PharmD, CGP, BCPP